Formulation and evaluation of pharmaceutically equivalent parenteral depot suspension of methyl prednisolone acetate.
about
Development and validation of a discriminative dissolution test for betamethasone sodium phosphate and betamethasone dipropionate intramuscular injectable suspension.Antihyperlipidemic activity of Salacia chinensis root extracts in triton-induced and atherogenic diet-induced hyperlipidemic rats.Human tissue-engineered skeletal muscle: a novel 3D in vitro model for drug disposition and toxicity after intramuscular injection
P2860
Formulation and evaluation of pharmaceutically equivalent parenteral depot suspension of methyl prednisolone acetate.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Formulation and evaluation of ...... f methyl prednisolone acetate.
@en
Formulation and evaluation of ...... f methyl prednisolone acetate.
@nl
type
label
Formulation and evaluation of ...... f methyl prednisolone acetate.
@en
Formulation and evaluation of ...... f methyl prednisolone acetate.
@nl
prefLabel
Formulation and evaluation of ...... f methyl prednisolone acetate.
@en
Formulation and evaluation of ...... f methyl prednisolone acetate.
@nl
P2093
P2860
P356
P1476
Formulation and evaluation of ...... f methyl prednisolone acetate.
@en
P2093
P2860
P356
10.4103/0250-474X.51949
P577
2009-01-01T00:00:00Z